Cardiosense
Chicago
About Cardiosense
Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. They mine raw biosignals for unprecedented visibility into cardiac functions. They also develop an advanced signal processing pipeline to identify pre-symptomatic markers of cardiac disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2022)
- Website: cardiosense.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Machine Learning, Predictive Analytics
Social Profiles
Canonical: https://fsome.com/organization/cardiosense-32725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.